NASDAQ:BASI - Bioanalytical Systems Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.35 -0.06 (-4.26 %) (As of 10/17/2018 04:01 AM ET)Previous Close$1.41Today's Range$1.35 - $1.4452-Week Range$1.37 - $2.95Volume18,845 shsAverage Volume44,927 shsMarket Capitalization$16.50 millionP/E RatioN/ADividend YieldN/ABeta0.97 Company ProfileDiscussionChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through Contract Research Services and Research Products segments. The Contract Research Services segment offers screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. It also provides in vivo sampling services for the continuous monitoring of chemical changes in life; preclinical and pathology services; product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to establish and confirm product purity, potency, and shelf life; and climate-controlled archiving services for its customers' data and samples. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana. Receive BASI News and Ratings via Email Sign-up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Commercial physical research Sub-IndustryN/A SectorMedical SymbolNASDAQ:BASI CUSIPN/A Webwww.basinc.com Phone765-463-4527 Debt Debt-to-Equity Ratio0.47 Current Ratio0.73 Quick Ratio0.62 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$24.24 million Price / Sales0.57 Cash Flow$0.2606 per share Price / Cash5.18 Book Value$0.90 per share Price / Book1.50 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$880,000.00 Net Margins1.06% Return on Equity4.43% Return on Assets1.66% Miscellaneous Employees155 Outstanding Shares10,240,000Market Cap$16.50 million Bioanalytical Systems (NASDAQ:BASI) Frequently Asked Questions What is Bioanalytical Systems' stock symbol? Bioanalytical Systems trades on the NASDAQ under the ticker symbol "BASI." How were Bioanalytical Systems' earnings last quarter? Bioanalytical Systems, Inc. (NASDAQ:BASI) announced its earnings results on Tuesday, August, 14th. The company reported $0.01 EPS for the quarter. The firm had revenue of $6.04 million for the quarter. Bioanalytical Systems had a net margin of 1.06% and a return on equity of 4.43%. View Bioanalytical Systems' Earnings History. When is Bioanalytical Systems' next earnings date? Bioanalytical Systems is scheduled to release their next quarterly earnings announcement on Tuesday, November 13th 2018. View Earnings Estimates for Bioanalytical Systems. Who are some of Bioanalytical Systems' key competitors? Some companies that are related to Bioanalytical Systems include Vitality Biopharma (VBIO), Dyadic International (DYAI), BIOQUAL (BIOQ), Cleveland BioLabs (CBLI), Protalex (PRTX), US Stem Cell (USRM), Tenax Therapeutics (TENX), Geovax Labs (GOVX), ALGAE TEC LTD/S (ALGXY) and Redpoint Bio (RPBC). Who are Bioanalytical Systems' key executives? Bioanalytical Systems' management team includes the folowing people: Mr. Philip A. Downing, Acting Principal Exec. Officer & Sr. VP of Preclinical Services (Age 48)Ms. Jill C. Blumhoff, Principal Accounting Officer, CFO & VP of Fin. (Age 42)Dr. Peter T. Kissinger, Founder, Chairman Emeritus and Scientific Advisor (Age 73)Ms. Erica Wasson, Director of HRMs. Stephanie Miller, Director of Client Services How do I buy shares of Bioanalytical Systems? Shares of BASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bioanalytical Systems' stock price today? One share of BASI stock can currently be purchased for approximately $1.35. How big of a company is Bioanalytical Systems? Bioanalytical Systems has a market capitalization of $16.50 million and generates $24.24 million in revenue each year. Bioanalytical Systems employs 155 workers across the globe. What is Bioanalytical Systems' official website? The official website for Bioanalytical Systems is http://www.basinc.com. How can I contact Bioanalytical Systems? Bioanalytical Systems' mailing address is 2701 KENT AVENUE, WEST LAFAYETTE IN, 47906. The company can be reached via phone at 765-463-4527 or via email at [email protected] MarketBeat Community Rating for Bioanalytical Systems (NASDAQ BASI)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 68 (Vote Outperform)Underperform Votes: 83 (Vote Underperform)Total Votes: 151MarketBeat's community ratings are surveys of what our community members think about Bioanalytical Systems and other stocks. Vote "Outperform" if you believe BASI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BASI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/17/2018 by MarketBeat.com StaffFeatured Article: What strategies should day traders use to execute a trade?